BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27422962)

  • 1. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
    Zeligs KP; Neuman MK; Annunziata CM
    Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment.
    Fouani L; Kovacevic Z; Richardson DR
    Antioxid Redox Signal; 2019 Mar; 30(8):1096-1123. PubMed ID: 29161883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
    Verzella D; Fischietti M; Capece D; Vecchiotti D; Del Vecchio F; Cicciarelli G; Mastroiaco V; Tessitore A; Alesse E; Zazzeroni F
    Curr Drug Targets; 2016; 17(3):311-20. PubMed ID: 26343112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
    Tang C; Zhu G
    Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.
    Yu L; Li L; Medeiros LJ; Young KH
    Blood Rev; 2017 Mar; 31(2):77-92. PubMed ID: 27773462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB in cancer therapy.
    Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
    Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
    de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
    Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer.
    Wu J; Ding J; Yang J; Guo X; Zheng Y
    Front Immunol; 2018; 9():546. PubMed ID: 29616037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB and the link between inflammation and cancer.
    DiDonato JA; Mercurio F; Karin M
    Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer.
    Greten FR; Karin M
    Cancer Lett; 2004 Apr; 206(2):193-9. PubMed ID: 15013524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NF-kappaB signalling pathway: a therapeutic target in lymphoid malignancies?
    Stoffel A
    Expert Opin Ther Targets; 2005 Oct; 9(5):1045-61. PubMed ID: 16185157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using NF-κB as a molecular target for theranostics in radiation oncology research.
    Liu YC; Chiang IT; Hsu FT; Hwang JJ
    Expert Rev Mol Diagn; 2012 Mar; 12(2):139-46. PubMed ID: 22369374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB as a potential molecular target for cancer therapy.
    Lee CH; Jeon YT; Kim SH; Song YS
    Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB signaling in cancer stem cells: a promising therapeutic target?
    Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
    Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt Signal Transduction Pathways and Nuclear Factor-kappa B (NF-κB) Transcription as a Molecular Target of Oral Tongue Squamous Cell Carcinoma (SP-C1) Using Papua's Anthill Plant ( Myrmecodia pendans ).
    Achmad H; Supriatno ; Singgih MF; Hendrastuti H
    Pak J Biol Sci; 2016; 19(8-9):323-330. PubMed ID: 29023018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the NF-κB pathway in cancer therapy.
    Erstad DJ; Cusack JC
    Surg Oncol Clin N Am; 2013 Oct; 22(4):705-46. PubMed ID: 24012396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to target NF-κB and other signaling pathways in cancer stem cells.
    Ukaji T; Umezawa K
    Adv Biol Regul; 2014 Sep; 56():108-15. PubMed ID: 25128192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB signaling and its relevance to the treatment of mantle cell lymphoma.
    Balaji S; Ahmed M; Lorence E; Yan F; Nomie K; Wang M
    J Hematol Oncol; 2018 Jun; 11(1):83. PubMed ID: 29907126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncanonical NF-κB Signaling in Health and Disease.
    Cildir G; Low KC; Tergaonkar V
    Trends Mol Med; 2016 May; 22(5):414-429. PubMed ID: 27068135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers.
    Li X; Abdel-Mageed AB; Mondal D; Kandil E
    Thyroid; 2013 Feb; 23(2):209-18. PubMed ID: 23273524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.